35 information-security "https:" "https:" "https:" "https:" "https:" "Dr" "Dr" Fellowship positions in Ireland
Sort by
Refine Your Search
-
education, research, admin Additional Information Website for additional job details https://www.ucd.ie/ Work Location(s) Number of offers available1Company/InstituteUCDCountryIrelandCityDublinGeofield
-
Marmelstein (g.marmelstein@tcd.ie) Please see the Job Description below for further information on this position or if on external website please apply directly on our Trinity Jobs Portal http://jobs.tcd.ie
-
Salary: €65,889 - €71,796 gross p.a. (IUA scale). For an information package including further details of the post see https://ore.ucc.ie/ Informal enquiries can be made in confidence to Dr. Andrew England
-
package including further details of the post see https://ore.ucc.ie/ Informal enquiries can be made in confidence to Dr. Andrew England, Medical Imaging & Radiation Therapy- School of Medicine. Email
-
Scale (pro rata 0.7FTE) For an information package including further details of the post see https://ore.ucc.ie/ Informal enquiries can be made in confidence to Dr. Paul Holloway, Senior Lecturer
-
first-in-human Phase 1 multi-centre trial of melatonin in this population, the aim is to evaluate the safety and pharmacokinetics of IV melatonin in term neonates with HIE receiving therapeutic
-
communication Additional Information Website for additional job details https://www.ucd.ie/ Work Location(s) Number of offers available1Company/Instituteuniversity college dublinCountryIrelandCityDublinGeofield
-
posts instead. Prior to application, further information (including application procedure) should be obtained from the Work at UCD website: https://www.ucd.ie/workatucd/jobs/ Where to apply Website https
-
posts instead. Prior to application, further information (including application procedure) should be obtained from the Work at UCD website: https://www.ucd.ie/workatucd/jobs/ Where to apply Website https
-
encephalopathy (HIE) undergoing therapeutic hypothermia (HT) treatment. As this is the first-in-human Phase 1 multi-centre trial of melatonin in this population, the aim is to evaluate the safety and